Semaglutide delivers superior weight loss results compared to Contrave, with clinical trials showing 15-17% average weight reduction versus 5-9% for the naltrexone/bupropion combination
Monitor Your Weight: Track your weight to ensure you dont start gaining once you stop using the GLP-1 medication and adjust if the scale is creeping up
, - , B, L () , L , (levo) ,
By harnessing the synergistic power of DSIP and Epithalon peptides, these innovative combinations offer a holistic approach to aging that addresses both physical and cognitive aspects of well-being
Don't use this stack if you're pregnant or nursing, under 18, have active cancer, or have contraindications to GLP-1 medications (medullary thyroid carcinoma history, MEN2 syndrome, pancreatitis history)